AKT1 and hepatocellular carcinoma: It was shown that in SAL treatment of human hepatocellular carcinoma cell line 97H, SAL decreased the phosphorylation of PI3K and AKT proteins and upregulated the protein expression levels of caspase3 and caspase910.